{"id":"W2064933772","doi":"10.1016/j.bbmt.2012.11.481","title":"A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD)","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Prednisone; Refractory (planetary science); Trough level; Internal medicine; Single Center; Corticosteroid; Nilotinib; Dosing; Pharmacokinetics; Gastroenterology; Pharmacology; Tacrolimus; Transplantation; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395431,0.001119119,0.001526167,0.0004989385,0.0004794172,0.0006802204,0.0004974451,0.0006736774,0.00165264],"category_scores_gemma":[0.0008168673,0.0004911862,0.0007572118,0.0003013188,0.0008596809,0.000843195,0.0003266665,0.002050228,0.000476374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007146019,"about_ca_system_score_gemma":0.0007727919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002839554,"about_ca_topic_score_gemma":0.001312716,"domain_scores_codex":[0.9995696,0.0001938244,0.00002027873,0.00008789468,0.00005240054,0.00007601213],"domain_scores_gemma":[0.9994191,0.00009865364,0.0001107869,0.00004835852,0.00003769568,0.0002854387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4908582,0.1401839,0.01612378,0.001194352,0.0014946,0.0007902128,0.000887477,0.004122064,0.1675641,0.0004169201,0.005455786,0.1709087],"study_design_scores_gemma":[0.3200093,0.6482562,0.02005278,0.00002640547,0.0002921029,0.0006264951,0.0000944397,0.001881916,0.006039856,0.0003189931,0.002350376,0.00005117838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966227,0.001014061,0.0004421802,0.0002098982,0.00004594637,0.0007329463,0.0003313788,0.00004966637,0.0005512259],"genre_scores_gemma":[0.9952562,0.0005747482,0.00125217,0.0004325727,0.00005632068,0.0007528534,0.0006818232,0.00001796204,0.0009752222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00165264,"threshold_uncertainty_score":0.00737983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04760983088244001,"score_gpt":0.3409495016617229,"score_spread":0.2933396707792829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}